From Concept to Platform: What Microsoft Discovery Is
Microsoft Discovery is an Azure-based agentic AI platform that lets organizations create, coordinate, and govern AI agent teams that run autonomous workflows across scientific and engineering R&D, connecting models, tools, and institutional knowledge in a repeatable loop from evidence to hypothesis, experiment, and review. Unlike single-chat assistants, Discovery is designed as an enterprise AI deployment environment: it integrates specialized modeling and simulation tools, internal data, and external scientific literature while keeping human experts in control. At its center, the Microsoft Discovery Engine manages multi-step research workflows, tracks tasks, and preserves reasoning paths so outputs remain reviewable and reproducible. Governance features such as data access controls and auditability aim to make agentic AI usable in regulated, IP-sensitive labs. With general availability on Azure and a desktop app preview linked to GitHub Copilot, Discovery now targets both large R&D organizations and smaller teams that want to formalize AI agent teams into production-grade scientific workflows.
Majorana 2: Quantum Hardware as a Proof of Agentic AI
Microsoft is using Discovery to prove that an agentic AI platform can influence high-stakes physics research, not just office automation. The company credits Discovery’s AI agent teams with helping develop Majorana 2, a next-generation topological quantum chip that delivers a reported 1,000-fold reliability improvement over its predecessor. Discovery’s agents coordinated fabrication workflows, automated measurements, optimized materials stacks, and sifted nearly two decades of experimental data in disparate formats to uncover subtle flaws in qubit manufacturing. Integrated with Azure high-performance computing, these autonomous workflows supported large volumes of simulations and analyses while providing confidence scores and cited findings so physicists could audit every step. Microsoft now expects to reach a scalable quantum computer by 2029, cutting its original timeline in half. This project shows how multi-agent research loops can systematically refine hardware designs, rather than leaving insights to manual trial-and-error across scattered tools and datasets.
Mining Innovation: BHP’s Copper Challenge and Autonomous Workflows
In mining, Discovery is tackling a decades-old problem central to the energy transition: more efficient copper extraction. Geochemists and data scientists at BHP worked with Microsoft and Prescience Insilico to screen more than 500,000 chemical reagents to improve copper leaching performance. Agentic AI teams running on Microsoft Discovery Azure infrastructure orchestrated tens of thousands of quantum chemistry calculations and simulations, rapidly narrowing the candidate list to molecules worth validating in physical labs. According to BHP Vice President Innovation Jessica Farrell, “This project is about giving our scientists excellent tools to focus on the most promising copper leaching solutions, sooner.” Discovery’s autonomous workflows combine literature review, hypothesis generation, and iterative simulation in a unified environment, so insights are linked back to their computational and data provenance. For BHP, this means faster decision cycles on which reagents to move into testing, with traceable evidence available to chemists and operational leaders.
Drug Discovery with Causaly: From Computational Signal to Biological Insight
Microsoft is extending Discovery into life sciences by pairing its computational engine with Causaly’s agentic AI platform for biomedical reasoning. Early drug discovery often stalls at target selection, where organizations must decide which biological mechanisms are worth pursuing before spending years on experiments. In this collaboration, Microsoft Discovery produces the computational signal: AI agent teams scan institutional and external data to surface patterns and possible targets. Causaly then judges whether those signals are biologically plausible, using curated biomedical knowledge graphs and explainable workflows that preserve provenance at each evidence gate, from mechanistic plausibility to prioritization. As Causaly CEO Yiannis Kiachopoulos notes, “Everything needs to be inspectable, you do not want black boxes.” The goal is to move from data to signal, and from signal to insight, reducing one of pharma’s most expensive and risky decisions while keeping scientific interpretability at the center of AI-driven pipelines.
Agentic AI Enters Production-Grade Scientific R&D
Taken together, Microsoft Discovery’s role in quantum hardware, mining innovation, and target discovery shows a clear shift in how agentic AI platforms are used. Instead of experimental bots sitting beside existing tools, Discovery positions AI agent teams as first-class participants in R&D programs, with governance strong enough for enterprise AI deployment. The platform is built around four design constraints: workflows must be reproducible, outputs reviewable, proprietary knowledge governed, and agent systems compatible with existing R&D operating models. That framing moves autonomous workflows from prototypes to production environments where scientists audit reasoning, re-run experiments, and refine agents as new evidence arrives. With Discovery now generally available on Azure and a desktop app in preview, Microsoft is betting that the next wave of AI impact will come not from single-model assistants but from orchestrated, auditable AI agent teams embedded deep in scientific and industrial pipelines.
